Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis
Postthrombotic syndrome (PTS) refers to manifestations of chronic venous insufficiency after a deep vein thrombosis (DVT). The risk of developing moderate-to-severe PTS in the very long term is largely unknown and particularly in case of distal DVT. Furthermore, the impact of DVT vs other causes of...
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and haemostasis 2024-11, Vol.22 (11), p.3148-3160 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3160 |
---|---|
container_issue | 11 |
container_start_page | 3148 |
container_title | Journal of thrombosis and haemostasis |
container_volume | 22 |
creator | Galanaud, Jean-Philippe Krebs-Drouot, Lila Genty-Vermorel, Céline Geerts, William Abdulrehman, Jameel Blaise, Sophie Böge, Gudrun Carpentier, Patrick Rolland, Carole Sevestre-Pietri, Marie-Antoinette Pernod, Gilles Giai, Joris Bosson, Jean-Luc |
description | Postthrombotic syndrome (PTS) refers to manifestations of chronic venous insufficiency after a deep vein thrombosis (DVT). The risk of developing moderate-to-severe PTS in the very long term is largely unknown and particularly in case of distal DVT. Furthermore, the impact of DVT vs other causes of chronic venous insufficiency on long-term manifestations of PTS is also unknown.
To assess the very long–term risk of moderate-to-severe PTS after DVT and the role that DVT plays in PTS symptoms.
Patients with lower-limb DVT enrolled in the multicenter Optimisation de l’interrogatoire dans l’evaluation du risque thromboembolique veineux (OPTIMEV) study underwent a very long–term telephone follow-up. We assessed i) the proportion of moderate-to-severe PTS (assessed with the patient-reported Villalta score) according to DVT extent and ii) the population attributable fraction that DVT plays in patients’ moderate-to-severe PTS manifestations.
Fourteen years after DVT, moderate-to-severe PTS developed in 35 of 185 patients with distal DVT (18.9%; 95% CI, 13.5%-25.3%), 11 of 47 patients with popliteal DVT (23.4%; 95% CI, 12.3%-38.0%), and 27 of 74 patients with iliofemoral DVT (36.5%; 95% CI, 25.6%-48.5%). The population attributable fraction of DVT in moderate-to-severe symptoms of PTS was 25.7% (−18.1% to 53.3%) in patients with distal DVT, 27.3% (−63.7% to 67.7%) in patients with popliteal DVT, and 43.1% (+0.7%-67.4%) in patients with iliofemoral DVT.
In the very long term after DVT, a quarter of patients have moderate-to-severe PTS manifestations. However, the impact of the DVT on these manifestations appears nonpredominant and varies according to DVT extent. Distal DVT does not significantly increase the risk of developing moderate-to-severe PTS. |
doi_str_mv | 10.1016/j.jtha.2024.07.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3091283699</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1538783624004380</els_id><sourcerecordid>3091283699</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-d7efcd7547b9cf6b62797470f72daf218fa0f19cc08b339ce90557f42cb543543</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMoXqov4EKydDNjkrlkAm5EvIHgRl0aZpITm9qZ1CQtdOc7-IY-iSmt4ko4kBP4_h_Oh9AxJTkltD6b5JM4bnNGWJkTnhNGttA-rYom401Rb__Z99BBCBNCqKgY2UV7haCMUVHso5dn8Es8dcPr18dnBN9jb8Mbdgb3ToNvI2TRZQEW4AHPXIhx7F3fuWgVDstBpw_g1qQk1gAzvAA74A0TbDhEO6adBjjavCP0dH31eHmb3T_c3F1e3GeKNTRmmoNRmlcl74QydVczLnjJieFMt4bRxrTEUKEUabqiEAoEqSpuSqa6qizSjNDpunfm3fscQpS9DQqm03YANw-yIOniJEKIhLI1qrwLwYORM2_71i8lJXLlVU7kyqtceZWEy-Q1hU42_fOuB_0b-RGZgPM1AOnKhQUvg7IwKNDWg4pSO_tf_zf8h4vg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3091283699</pqid></control><display><type>article</type><title>Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis</title><source>Alma/SFX Local Collection</source><creator>Galanaud, Jean-Philippe ; Krebs-Drouot, Lila ; Genty-Vermorel, Céline ; Geerts, William ; Abdulrehman, Jameel ; Blaise, Sophie ; Böge, Gudrun ; Carpentier, Patrick ; Rolland, Carole ; Sevestre-Pietri, Marie-Antoinette ; Pernod, Gilles ; Giai, Joris ; Bosson, Jean-Luc</creator><creatorcontrib>Galanaud, Jean-Philippe ; Krebs-Drouot, Lila ; Genty-Vermorel, Céline ; Geerts, William ; Abdulrehman, Jameel ; Blaise, Sophie ; Böge, Gudrun ; Carpentier, Patrick ; Rolland, Carole ; Sevestre-Pietri, Marie-Antoinette ; Pernod, Gilles ; Giai, Joris ; Bosson, Jean-Luc ; Optimisation de l'interrogatoire dans l evaluation du risque thromboembolique veineux - Societe Francaise de Medecine Vasculaire investigators</creatorcontrib><description>Postthrombotic syndrome (PTS) refers to manifestations of chronic venous insufficiency after a deep vein thrombosis (DVT). The risk of developing moderate-to-severe PTS in the very long term is largely unknown and particularly in case of distal DVT. Furthermore, the impact of DVT vs other causes of chronic venous insufficiency on long-term manifestations of PTS is also unknown.
To assess the very long–term risk of moderate-to-severe PTS after DVT and the role that DVT plays in PTS symptoms.
Patients with lower-limb DVT enrolled in the multicenter Optimisation de l’interrogatoire dans l’evaluation du risque thromboembolique veineux (OPTIMEV) study underwent a very long–term telephone follow-up. We assessed i) the proportion of moderate-to-severe PTS (assessed with the patient-reported Villalta score) according to DVT extent and ii) the population attributable fraction that DVT plays in patients’ moderate-to-severe PTS manifestations.
Fourteen years after DVT, moderate-to-severe PTS developed in 35 of 185 patients with distal DVT (18.9%; 95% CI, 13.5%-25.3%), 11 of 47 patients with popliteal DVT (23.4%; 95% CI, 12.3%-38.0%), and 27 of 74 patients with iliofemoral DVT (36.5%; 95% CI, 25.6%-48.5%). The population attributable fraction of DVT in moderate-to-severe symptoms of PTS was 25.7% (−18.1% to 53.3%) in patients with distal DVT, 27.3% (−63.7% to 67.7%) in patients with popliteal DVT, and 43.1% (+0.7%-67.4%) in patients with iliofemoral DVT.
In the very long term after DVT, a quarter of patients have moderate-to-severe PTS manifestations. However, the impact of the DVT on these manifestations appears nonpredominant and varies according to DVT extent. Distal DVT does not significantly increase the risk of developing moderate-to-severe PTS.</description><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1016/j.jtha.2024.07.020</identifier><identifier>PMID: 39122193</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>cohort studies ; postthrombotic syndrome ; venous thrombosis</subject><ispartof>Journal of thrombosis and haemostasis, 2024-11, Vol.22 (11), p.3148-3160</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c281t-d7efcd7547b9cf6b62797470f72daf218fa0f19cc08b339ce90557f42cb543543</cites><orcidid>0000-0003-2705-3615</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39122193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Galanaud, Jean-Philippe</creatorcontrib><creatorcontrib>Krebs-Drouot, Lila</creatorcontrib><creatorcontrib>Genty-Vermorel, Céline</creatorcontrib><creatorcontrib>Geerts, William</creatorcontrib><creatorcontrib>Abdulrehman, Jameel</creatorcontrib><creatorcontrib>Blaise, Sophie</creatorcontrib><creatorcontrib>Böge, Gudrun</creatorcontrib><creatorcontrib>Carpentier, Patrick</creatorcontrib><creatorcontrib>Rolland, Carole</creatorcontrib><creatorcontrib>Sevestre-Pietri, Marie-Antoinette</creatorcontrib><creatorcontrib>Pernod, Gilles</creatorcontrib><creatorcontrib>Giai, Joris</creatorcontrib><creatorcontrib>Bosson, Jean-Luc</creatorcontrib><creatorcontrib>Optimisation de l'interrogatoire dans l evaluation du risque thromboembolique veineux - Societe Francaise de Medecine Vasculaire investigators</creatorcontrib><title>Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Postthrombotic syndrome (PTS) refers to manifestations of chronic venous insufficiency after a deep vein thrombosis (DVT). The risk of developing moderate-to-severe PTS in the very long term is largely unknown and particularly in case of distal DVT. Furthermore, the impact of DVT vs other causes of chronic venous insufficiency on long-term manifestations of PTS is also unknown.
To assess the very long–term risk of moderate-to-severe PTS after DVT and the role that DVT plays in PTS symptoms.
Patients with lower-limb DVT enrolled in the multicenter Optimisation de l’interrogatoire dans l’evaluation du risque thromboembolique veineux (OPTIMEV) study underwent a very long–term telephone follow-up. We assessed i) the proportion of moderate-to-severe PTS (assessed with the patient-reported Villalta score) according to DVT extent and ii) the population attributable fraction that DVT plays in patients’ moderate-to-severe PTS manifestations.
Fourteen years after DVT, moderate-to-severe PTS developed in 35 of 185 patients with distal DVT (18.9%; 95% CI, 13.5%-25.3%), 11 of 47 patients with popliteal DVT (23.4%; 95% CI, 12.3%-38.0%), and 27 of 74 patients with iliofemoral DVT (36.5%; 95% CI, 25.6%-48.5%). The population attributable fraction of DVT in moderate-to-severe symptoms of PTS was 25.7% (−18.1% to 53.3%) in patients with distal DVT, 27.3% (−63.7% to 67.7%) in patients with popliteal DVT, and 43.1% (+0.7%-67.4%) in patients with iliofemoral DVT.
In the very long term after DVT, a quarter of patients have moderate-to-severe PTS manifestations. However, the impact of the DVT on these manifestations appears nonpredominant and varies according to DVT extent. Distal DVT does not significantly increase the risk of developing moderate-to-severe PTS.</description><subject>cohort studies</subject><subject>postthrombotic syndrome</subject><subject>venous thrombosis</subject><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKAzEUhoMoXqov4EKydDNjkrlkAm5EvIHgRl0aZpITm9qZ1CQtdOc7-IY-iSmt4ko4kBP4_h_Oh9AxJTkltD6b5JM4bnNGWJkTnhNGttA-rYom401Rb__Z99BBCBNCqKgY2UV7haCMUVHso5dn8Es8dcPr18dnBN9jb8Mbdgb3ToNvI2TRZQEW4AHPXIhx7F3fuWgVDstBpw_g1qQk1gAzvAA74A0TbDhEO6adBjjavCP0dH31eHmb3T_c3F1e3GeKNTRmmoNRmlcl74QydVczLnjJieFMt4bRxrTEUKEUabqiEAoEqSpuSqa6qizSjNDpunfm3fscQpS9DQqm03YANw-yIOniJEKIhLI1qrwLwYORM2_71i8lJXLlVU7kyqtceZWEy-Q1hU42_fOuB_0b-RGZgPM1AOnKhQUvg7IwKNDWg4pSO_tf_zf8h4vg</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Galanaud, Jean-Philippe</creator><creator>Krebs-Drouot, Lila</creator><creator>Genty-Vermorel, Céline</creator><creator>Geerts, William</creator><creator>Abdulrehman, Jameel</creator><creator>Blaise, Sophie</creator><creator>Böge, Gudrun</creator><creator>Carpentier, Patrick</creator><creator>Rolland, Carole</creator><creator>Sevestre-Pietri, Marie-Antoinette</creator><creator>Pernod, Gilles</creator><creator>Giai, Joris</creator><creator>Bosson, Jean-Luc</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2705-3615</orcidid></search><sort><creationdate>20241101</creationdate><title>Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis</title><author>Galanaud, Jean-Philippe ; Krebs-Drouot, Lila ; Genty-Vermorel, Céline ; Geerts, William ; Abdulrehman, Jameel ; Blaise, Sophie ; Böge, Gudrun ; Carpentier, Patrick ; Rolland, Carole ; Sevestre-Pietri, Marie-Antoinette ; Pernod, Gilles ; Giai, Joris ; Bosson, Jean-Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-d7efcd7547b9cf6b62797470f72daf218fa0f19cc08b339ce90557f42cb543543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>cohort studies</topic><topic>postthrombotic syndrome</topic><topic>venous thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galanaud, Jean-Philippe</creatorcontrib><creatorcontrib>Krebs-Drouot, Lila</creatorcontrib><creatorcontrib>Genty-Vermorel, Céline</creatorcontrib><creatorcontrib>Geerts, William</creatorcontrib><creatorcontrib>Abdulrehman, Jameel</creatorcontrib><creatorcontrib>Blaise, Sophie</creatorcontrib><creatorcontrib>Böge, Gudrun</creatorcontrib><creatorcontrib>Carpentier, Patrick</creatorcontrib><creatorcontrib>Rolland, Carole</creatorcontrib><creatorcontrib>Sevestre-Pietri, Marie-Antoinette</creatorcontrib><creatorcontrib>Pernod, Gilles</creatorcontrib><creatorcontrib>Giai, Joris</creatorcontrib><creatorcontrib>Bosson, Jean-Luc</creatorcontrib><creatorcontrib>Optimisation de l'interrogatoire dans l evaluation du risque thromboembolique veineux - Societe Francaise de Medecine Vasculaire investigators</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galanaud, Jean-Philippe</au><au>Krebs-Drouot, Lila</au><au>Genty-Vermorel, Céline</au><au>Geerts, William</au><au>Abdulrehman, Jameel</au><au>Blaise, Sophie</au><au>Böge, Gudrun</au><au>Carpentier, Patrick</au><au>Rolland, Carole</au><au>Sevestre-Pietri, Marie-Antoinette</au><au>Pernod, Gilles</au><au>Giai, Joris</au><au>Bosson, Jean-Luc</au><aucorp>Optimisation de l'interrogatoire dans l evaluation du risque thromboembolique veineux - Societe Francaise de Medecine Vasculaire investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>22</volume><issue>11</issue><spage>3148</spage><epage>3160</epage><pages>3148-3160</pages><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Postthrombotic syndrome (PTS) refers to manifestations of chronic venous insufficiency after a deep vein thrombosis (DVT). The risk of developing moderate-to-severe PTS in the very long term is largely unknown and particularly in case of distal DVT. Furthermore, the impact of DVT vs other causes of chronic venous insufficiency on long-term manifestations of PTS is also unknown.
To assess the very long–term risk of moderate-to-severe PTS after DVT and the role that DVT plays in PTS symptoms.
Patients with lower-limb DVT enrolled in the multicenter Optimisation de l’interrogatoire dans l’evaluation du risque thromboembolique veineux (OPTIMEV) study underwent a very long–term telephone follow-up. We assessed i) the proportion of moderate-to-severe PTS (assessed with the patient-reported Villalta score) according to DVT extent and ii) the population attributable fraction that DVT plays in patients’ moderate-to-severe PTS manifestations.
Fourteen years after DVT, moderate-to-severe PTS developed in 35 of 185 patients with distal DVT (18.9%; 95% CI, 13.5%-25.3%), 11 of 47 patients with popliteal DVT (23.4%; 95% CI, 12.3%-38.0%), and 27 of 74 patients with iliofemoral DVT (36.5%; 95% CI, 25.6%-48.5%). The population attributable fraction of DVT in moderate-to-severe symptoms of PTS was 25.7% (−18.1% to 53.3%) in patients with distal DVT, 27.3% (−63.7% to 67.7%) in patients with popliteal DVT, and 43.1% (+0.7%-67.4%) in patients with iliofemoral DVT.
In the very long term after DVT, a quarter of patients have moderate-to-severe PTS manifestations. However, the impact of the DVT on these manifestations appears nonpredominant and varies according to DVT extent. Distal DVT does not significantly increase the risk of developing moderate-to-severe PTS.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>39122193</pmid><doi>10.1016/j.jtha.2024.07.020</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-2705-3615</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1538-7836 |
ispartof | Journal of thrombosis and haemostasis, 2024-11, Vol.22 (11), p.3148-3160 |
issn | 1538-7836 1538-7836 |
language | eng |
recordid | cdi_proquest_miscellaneous_3091283699 |
source | Alma/SFX Local Collection |
subjects | cohort studies postthrombotic syndrome venous thrombosis |
title | Very long–term risk of moderate-to-severe postthrombotic syndrome after deep vein thrombosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A36%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Very%20long%E2%80%93term%20risk%20of%20moderate-to-severe%20postthrombotic%20syndrome%20after%20deep%20vein%20thrombosis&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=Galanaud,%20Jean-Philippe&rft.aucorp=Optimisation%20de%20l'interrogatoire%20dans%20l%20evaluation%20du%20risque%20thromboembolique%20veineux%20-%20Societe%20Francaise%20de%20Medecine%20Vasculaire%20investigators&rft.date=2024-11-01&rft.volume=22&rft.issue=11&rft.spage=3148&rft.epage=3160&rft.pages=3148-3160&rft.issn=1538-7836&rft.eissn=1538-7836&rft_id=info:doi/10.1016/j.jtha.2024.07.020&rft_dat=%3Cproquest_cross%3E3091283699%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3091283699&rft_id=info:pmid/39122193&rft_els_id=S1538783624004380&rfr_iscdi=true |